Yue He, Huazhong University of Science and Technology, China Updates Copyright 2021 Huang, Li, Feng and Chen
Subbaramaiah K, Yoshimatsu K, Scherl E, et al
McGraw-Hill / Lange rxlist.com (Actos ) Keywords Alpha-Glucosidase Inhibitors Acarbose Trade Names: Precose Drug Class: oral hypoglycemic, -glucosidase inhibitor Mechanism of Action: inhibits the activity of enzymes required to break carbohydrates down into simple sugars within the intestine Miglitol (Glyset ) is six times more potent in inhibiting sucrase than acarbose Indications: FDA approved: as adjunct therapy in type II diabetes mellitus Non-FDA approved: potentially beneficial in Type 1 diabetes
FDA approval for orforglipron in March 2026
MOTS-c has been shown to increase insulin-independent glucose uptake into skeletal muscle
We need to support them and help them navigate a world where dangerous substances are available with a few clicks